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Abstract
Background Differential diagnosis of patients with bilateral lung
infiltrates remains a difficult problem for intensive care clinicians.
Here we evaluate the diagnostic role of soluble triggering
receptor expressed on myeloid cells-1 (sTREM-1) in
bronchoalveolar lavage (BAL) specimens from patients with
bilateral lung infiltrates.
Methods We conducted a prospective observational study on
80 patients with bilateral lung infiltrates with clinical suspicion of
infectious pneumonia. Patients were categorized into three
groups: bacterial or fungal infection, intracellular or viral
infection, and noninfectious inflammatory disease. sTREM-1
concentrations were measured, and BAL fluid and Clinical
Pulmonary Infection Score (CPIS) were analyzed.
Results The sTREM-1 concentration was significantly
increased in patients with bacterial or fungal pneumonia (n = 29,
521.2 ± 94.7 pg/ml), compared with that in patients with viral
pneumonia, atypical pneumonia or tuberculosis (n = 14, 92.9 ±
20.0 pg/ml) or noninfectious inflammatory disease (n = 37, 92.8
± 10.7 pg/ml). The concentration of sTREM-1 in BAL fluid, but
not CPIS, was an independent predictor of bacterial or fungal
pneumonia, and a cutoff value of more than 184 pg/ml yielded a
diagnostic sensitivity of 86% and a specificity of 90%.
Conclusion The sTREM-1 level in BAL fluid from patients with
bilateral lung infiltrates is a potential marker for the differential
diagnosis of pneumonia due to extracellular bacteria.
Introduction
Differential diagnosis of patients with bilateral lung infiltrates
remains a difficult problem for intensive care clinicians. Diverse
presumptive clinical diagnoses of bilateral lung infiltrates
include severe pneumonia induced by bacteria, virus, fungi or
tuberculosis, and noninfectious inflammatory diseases caused
by collagen vascular disease associated with interstitial lung
disease, acute exacerbation of interstitial lung disease, pulmo-
nary edema, acute respiratory distress syndrome or drug-
induced lung disease [1]. Notably, several noninfectious proc-
esses other than pneumonia lead to fever, leukocytosis, hypox-
emia, purulent tracheal secretions, and diffuse pulmonary
infiltrates. To enhance the specificity of clinical criteria for diag-
nosing ventilator-associated pneumonia, the Clinical Pulmo-
nary Infection Score (CPIS) was introduced, which showed a
high diagnostic accuracy for ventilator-associated pneumonia
in some cases [2,3]. Gibot and colleagues also showed that
CPIS could differentiate between patients with and without
pneumonia [4]. However, the utility of CPIS remains to be val-
idated, particularly in patients with bilateral infiltration [5]. The
need for serology and microbiological tests could delay differ-
ential diagnosis for 48 to 72 hours, and the positive culture
rate may be low [6-8].
BAL = bronchoalveolar lavage; CI = confidence interval; CPIS = Clinical Pulmonary Infectious Score; NBL = non-directed bronchial lavage; ROC = 
receiver operating characteristic; sTREM-1 = soluble triggering receptor expressed on myeloid cells-1; TREMs = triggering receptors expressed on 
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Triggering receptors expressed on myeloid cells (TREMs) are
members of the immunoglobulin (Ig) superfamily, a critical
component of the innate immune defense system against
infection [9,10]. TREM-1 expression is upregulated by extra-
cellular bacteria and fungi but is weak in mycobacterial, viral,
intracellular bacterial, and noninfectious inflammatory disor-
ders [10-15]. However, there are conflicting reports on the
potential function of soluble TREM-1 (sTREM-1) in bronchoal-
veolar lavage (BAL) fluid as a biomarker of ventilator-associ-
ated pneumonia measured by mini-bronchoalveolar lavage or
non-directed bronchial lavage (NBL) [4,16-19]. Consequently,
more clinical evidence is required to establish the diagnostic
role of sTREM-1 in BAL fluid. In this study we focus solely on
patients with bilateral lung infiltrates, regardless of mechanical
ventilation.
Materials and methods
Study population
We enrolled 122 patients with bilateral lung infiltrates on the
basis of clinical suspicion of infectious pneumonia, hospital-
ized in our medical intensive care unit between 1 April 2004
and 30 September 2005 (Figure 1) [2,20]. The study was
approved by the Institutional Review Board of the Asan Medi-
cal Center, and written informed consent was obtained from
patients or their relatives. Eligibility criteria included the follow-
ing: (1) immunocompetent state, (2) age more than 18 years,
(3) bilateral lung infiltrates on chest radiography at admission
to the intensive care unit; and at least two of the following con-
ditions: purulent sputum, temperature more than 38.3°C or
leukocyte count of less than 4,000 or more than 11,000/mm3
(4) within 24 hours of administration of the initial antibiotic
therapy or immunosuppressive therapy before BAL. In total, 42
patients were excluded because of previous treatment with
nonspecific broad-spectrum antibiotics (39 patients) and an
immunosuppressive state (3 patients).
BAL was performed within 24 hours of admission at the inten-
sive care unit. Additional variables recorded during admission
included C-reactive protein, duration of mechanical ventilation,
and length of stay in the intensive care unit. CPIS was calcu-
lated as described in a previous report [2].
Two intensivists reviewed all patient medical records and inde-
pendently classified bilateral lung infiltrate diagnoses. A con-
sensus about diagnosis was achieved in all cases. Both
intensivists were unaware of the results of sTREM-1 measure-
ments in BAL fluid. On the basis of clinical, radiological, and
microbiological data, patients were assigned to one of three
groups (Table 1). Group A (n = 37) consisted of patients with
noninfectious diseases (for example acute exacerbation of
interstitial lung disease, collagen vascular disease-associated
lung disease, pulmonary edema, acute respiratory distress
syndrome – excluding bacterial pneumonia or drug-induced
lung disease). Group B (n = 14) included patients with tuber-
culosis, viral pneumonia, or atypical intracellular bacteria.
Group C (n = 29) comprised patients with extracellular bacte-
rial and fungal infections.
Definition of disease
Patients were diagnosed with non-infectious inflammatory eti-
ology, on the basis of clinical data, radiological signs, BAL
findings, and lung biopsy. The extent of interstitial lung disease
exacerbation was based on the criteria of Kondoh and col-
leagues [21]. These conditions included: (1) aggravation of
dyspnea within 1 month, (2) hypoxemia with a ratio of arterial
oxygen tension to inspired oxygen tension of less than 225, (3)
newly developing pulmonary infiltrates on chest radiography,
and (4) absence of apparent infection or heart disease. The
diagnosis of extracellular bacterial or fungal pneumonia was
based on positive blood culture or quantitative culture of BAL
fluid, or a rapid response of clinical symptoms and signs to
antibiotic therapy. The concentration of clinically significant
microorganisms for potential diagnosis of bacterial pneumonia
was more than 104 colony-forming units per ml of BAL fluid
[8,22,23]. Pneumonia due to atypical intracellular bacteria
(Mycoplasma pneumoniae and Legionella pneumoniae) was
diagnosed on the basis of positive serologic tests showing a
fourfold or greater increase in the antibody titer in paired
serum samples. Diagnosis of viral pneumonia was based on
clinical data, serologic tests, radiological signs [24], and
biopsies.
Assay of sTREM-1 in bronchoalveolar lavage fluid
Flexible bronchoscopy was performed on patients sedated
with midazolam. BAL was performed either in the right middle
lobe or the lingual segment by using 150 ml of sterile physio-
logical saline solution in three consecutive 50 ml aliquots. The
initial aspirated fluid underwent microbiological screening, and
subsequent aliquots were collected for BAL analysis and
sTREM-1. BAL fluid was subsequently filtered through sterile
gauze to remove mucus, and then centrifuged at 500 g and
Figure 1
Flow diagram of patients displaying bilateral infiltration with clinical sus- picion of infectious pneumonia admitted Flow diagram of patients displaying bilateral infiltration with clinical sus-
picion of infectious pneumonia admitted.Available online http://ccforum.com/content/12/1/R6
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4°C for 15 min to obtain the cell pellet. The supernatant was
centrifuged, separated, and stored as aliquots at -80°C until
further analysis.
The sTREM-1 concentration in BAL fluid samples was meas-
ured with a DuoSet enzyme-linked immunosorbent assay kit
(R&D Systems, Minneapolis, MN, USA) [16,18] consisting of
a capture antibody (mouse anti-human TREM-1), standard
antibody (recombinant human TREM-1), and detection anti-
body (biotinylated goat anti-human TREM-1). Intra-assay and
inter-assay coefficients of variation were 2.8% and 5.2%,
respectively.
Statistical methods
Categorical data were compared by using Fisher's exact test,
and continuous data were compared with the Kruskal–Wallis
test. To evaluate the diagnostic value of data we used a logis-
tic regression model. Receiver operating characteristic (ROC)
curves were constructed to illustrate the various cutoff values
of sTREM-1, CPIS, and neutrophil count in BAL fluid. Contin-
uous variables are expressed as mean ± SEM, and two-tailed
P values of less than 0.05 were considered statistically signif-
icant. All data were analyzed with SPSS version 11.0 (SPSS
Inc, Chicago, IL, USA).
Results
Patient characteristics
Characteristics of the study subjects are shown in Table 2.
Groups A and B displayed similar clinical and laboratory fea-
tures. In contrast, group C displayed neutrophilia in BAL fluid
and a high CPIS score compared with group A (Table 3). Path-
ogens were cultured in 76% of samples from group C patients
(Table 1).
The sTREM-1 concentration was significantly elevated in
group C (521.2 ± 94.7 pg/ml), compared with groups A (92.8
± 10.7 pg/ml, P < 0.05) and B (92.9 ± 20.0 pg/ml, P < 0.05)
(Figure 2). Subgroup analysis of group C (community-
acquired pneumonia, nosocomial pneumonia, and ventilator-
associated pneumonia) disclosed that sTREM-1 concentra-
tions were not significantly different between the three sub-
groups (Additional File 1).
Diagnostic value of the sTREM-1 assay
We employed ROC curve analysis (Figure 3) to determine
whether the sTREM-1 concentration in BAL fluid can be used
to discriminate between the possible causes of bilateral lung
infiltrates. The area under the ROC curve, using sTREM-1 to
differentiate between the presence and the absence of bacte-
rial and fungal pneumonia, was 0.91 (95% confidence interval
(CI) 0.83 to 0.98; P < 0.001). A sTREM-1 cutoff value of 184
pg/ml correlated with sensitivity and specificity values of 86%
(95% CI 72.9 to 99.6) and 90% (95% CI 81.8 to 98.7),
respectively. A positive likelihood ratio of 8.79, a negative like-
lihood ratio of 0.11, and an odds ratio of 57.50 (95% CI 14.15
to 233.66) were calculated. At a level of 184 pg/ml or higher,
sTREM-1 was detected in BAL fluid from 25 of 29 patients
with bacterial or fungal pneumonia (sensitivity 86%; 4 false-
negative results), 4 of 37 patients with noninfectious inflamma-
tory disease (4 false-positive results), and 1 of 14 patients with
atypical pneumonia, viral pneumonia, or tuberculosis (1 false-
positive result). Three of the five false-positive cases showed
diffuse alveolar hemorrhage in BAL fluid without reference to
infection. On exclusion of patients with diffuse alveolar
hemorrhage, the sTREM-1 cutoff value of 184 pg/ml yielded
sensitivity and specificity values of 92% (95% CI 80.6 to 100)
and 95% (95% CI 87.6 to 100), respectively.
Table 1
Grouping of study subjects with bilateral lung infiltrates
Group Diagnosis (n)
A Acute exacerbation of interstitial lung disease (10)
(n = 37) Collagen vascular disease-associated lung diseasea (6)
Radiation pneumonitis (4)
Drug-induced lung disease (3)
Othersb(14)
B Atypical pneumonia (4)
(n = 14) Cytomegalovirus pneumonia (3)
Pulmonary tuberculosis (2)
Leptospirosis (2)
Pneumocystis jiroveci pneumonia (2)
Herpes simplex virus pneumonia (1)
C Bacterial pneumonia (27)
(n = 29) Methicillin-resistant Staphylococcus aureus (9)
Methicillin-susceptible Staphylococcus aureus (1)
Pseudomonas aeruginosa (5)
Klebsiella pneumoniae (2)
Hemophilus influenza (1)
ESBL K. pneumoniae (1)
Stenotrophomonas maltophilia (1)
Unknown (7)
Fungal pneumonia (2)
Candida glabrata (1)
Aspergillosis (1)
ESBL, extended-spectrum β-lactamase.
aCollagen vascular disease-associated lung disease: vasculitis (n = 
3), rheumatoid arthritis (n = 1), dermatomyositis (n = 1), and 
systemic lupus erythematosus (n = 1). bOther: acute respiratory 
distress syndrome (n = 3), malignancy-associated lung disease (n = 
3), hypersensitivity pneumonia (n = 2), acute eosinophilic pneumonia 
(n = 2), diffuse alveolar damage (n = 1), pulmonary edema (n = 1), 
sarcoidosis (n = 1), and postpartum hemorrhage (n = 1).Critical Care    Vol 12 No 1    Huh et al.
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A multiple logistic regression analysis showed that the
sTREM-1 level (184 pg/ml) in BAL fluid is an independent
predictor of bacterial or fungal pneumonia with an odds ratio
of 59.742 (95% CI 6.610 to 539.930) (Table 4). No correla-
tion was evident between the neutrophil count and sTREM-1
in BAL fluid (r = 0.214, P = 0.069).
Discussion
The main findings of this study are that sTREM-1 concentra-
tion can be used effectively in the diagnosis of bacterial or fun-
gal pneumonia in patients with bilateral infiltration, and that a
modified CPIS of more than 6 is not a valid diagnostic indica-
tor of pneumonia using multivariate analysis.
Table 2
Characteristics of patients with bilateral lung infiltrates
Characteristic Group A (n = 37) Group B (n = 14) Group C (n = 29)
Age, years 57.8 ± 2.8 63.7 ± 3.4 61.7 ± 3.3
Sex, M:F 22:15 10:4 23:6
APACHE II score at entry 18.1 ± 1.0 16.8 ± 1.4 21.6 ± 1.4a
Co-morbidities, n
Malignancy 12 6
Chronic heart disease 2 1 1
Chronic lung disease 2 3
Chronic liver disease 1 2
Chronic renal disease 1 1
Endocrinologic disease 4
Neurologic disease 2 6
Transplantation 1 1
Duration of mechanical ventilation, days 11.3 ± 1.7 10.2 ± 3.6 11.2 ± 2.7
Length of stay in ICU, days 16.3 ± 2.2 10.9 ± 3.1 18.3 ± 2.7a
Mortality in ICU, percentage 40.5 28.6 42.9
Results are presented as mean ± SEM. Group A: noninfectious; group BI virus, tuberculosis, intracellular bacteria; group C: extracellular bacteria, 
fungi. APACHE, Acute Physiology and Chronic Health Evaluation; ICU, intensive care unit.
aP < 0.05 versus group B.
Table 3
Characteristics of the three groups of patients with bilateral lung infiltrates at enrollment
Characteristic Group A (n = 37) Group B (n = 14) Group C (n = 29)
CPIS 6.4 ± 0.4 7.4 ± 0.4 8.8 ± 0.4a
C-reactive protein, mg/dl 11.0 ± 1.5 14.0 ± 2.0 12.6 ± 2.6
BAL fluid findings, percentage
Neutrophils 34.6 ± 8.6 36.0 ± 15.0 66.7 ± 7.0a
Alveolar macrophages 29.3 ± 8.0 28.7 ± 6.4 15.7 ± 4.1a
Lymphocytes 22.5 ± 6.1 24.5 ± 10.9 11.2 ± 5.3
Eosinophils 7.0 ± 3.4 8.2 ± 5.2 3.7 ± 2.6
sTREM-1, pg/ml 92.8 ± 10.7 92.9 ± 20.0 521.2 ± 94.7a b
Results are presented as mean ± SEM. Group A: noninfectious; group B: virus, tuberculosis, intracellular bacteria; group C: extracellular bacteria, 
fungi. CPIS, Clinical Pulmonary Infection Score; BAL, bronchoalveolar lavage; sTREM-1, soluble triggering receptor expressed on myeloid cells-1.
aP < 0.05 versus group A; bP < 0.05 versus group B.Available online http://ccforum.com/content/12/1/R6
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In cases where patients displayed localized consolidation on a
chest radiogram, diagnosing pneumonia is less difficult than
identifying the cause of bilateral infiltration. The appropriate
diagnosis of bilateral lung infiltrates in critically ill patients is
crucial but difficult. In many cases, bilateral lung infiltrates are
associated with noninfectious inflammatory diseases.
Although previous reports show that a CPIS of more than 6
indicates a high likelihood of pneumonia, its diagnostic accu-
racy in bilateral lung infiltrates is controversial [2,4]. A CPIS
value greater than 6 was also a useful screening tool (82%
sensitivity) in the present study, but its specificity for differen-
tial diagnosis of bilateral bacterial pneumonia was low (39%).
In contrast to our findings, Gibot and colleagues reported that
CPIS could be effectively applied to differentiate between
patients with and without pneumonia (including community-
acquired pneumonia). Our study included 68.4% of patients
with a CPIS of more than 6, compared with 49% of patients in
Gigot's study. It therefore seems that a CPIS of more than 6 is
not an efficient factor in the diagnosis of pneumonia with bilat-
eral lung infiltrates.
Several earlier studies have focused on sTREM-1 in patients
with pneumonia. The present study, however, involved only
bilateral lung infiltration and took into consideration several
cases of acute exacerbation of interstitial lung disease, which
is difficult to distinguish from superimposed pneumonia.
Although some patients with bilateral infiltration were analyzed
by Gibot and colleagues, this condition was not the focus of
the earlier study. In addition, Gibot and colleagues did not
include patients with acute exacerbation of idiopathic pulmo-
nary fibrosis or viral pneumonia [4]. In another study, Richeldi
and coworkers did not include patients with pneumonia
caused by 'atypical' intracellular pathogens or fungi or those
admitted to the intensive care unit, and employed cytofluori-
metric analysis [25]. Our results not only confirm several pre-
vious findings but also provide additional information.
Here we show that the sTREM-1 level in BAL fluid constitutes
an independent factor in the differential diagnosis of bacterial
or fungal pneumonia at a cutoff level higher than 184 pg/ml.
Determann and coworkers reported that at a cutoff value of
200 pg/ml, sTREM-1 levels in NBL fluid in ventilator-associ-
ated pneumonia yielded diagnostic sensitivity and specificity
values of 75% and 84%, respectively [16]. This study was per-
formed with bronchoscopic BAL fluid instead of NBL fluid.
Previous data were obtained primarily with NBL fluid, which
may differ from BAL fluid in terms of specific characteristics.
However, the sTREM-1 levels were not significantly different
between BAL fluid and NBL fluid.
In the present study we observed no correlation between neu-
trophil counts and sTREM-1 levels in BAL fluid, indicating that
activation of neutrophils and amplification of the inflammatory
response occur via different mechanisms. sTREM-1 may have
a role in acute inflammation characterized by an exudate of
Figure 2
Concentration of sTREM-1 in bronchoalveolar lavage fluid of patients  with bilateral lung infiltrates Concentration of sTREM-1 in bronchoalveolar lavage fluid of patients 
with bilateral lung infiltrates. Group A, noninfectious inflammatory dis-
ease; group B, atypical pneumonia, viral pneumonia, and tuberculosis; 
group C, bacterial or fungal pneumonia. Individual values are plotted; 
bars represent the median values. sTREM-1, soluble triggering receptor 
expressed on myeloid cells-1.
Figure 3
ROC curve of sTREM-1, neutrophil percentage in BAL fluid, and CPIS  for diagnosis of bacterial and fungal pneumonia ROC curve of sTREM-1, neutrophil percentage in BAL fluid, and CPIS 
for diagnosis of bacterial and fungal pneumonia. Areas under the 
receiver operating characteristic (ROC) curve were 0.91 (95% confi-
dence interval (CI), 0.83 to 0.98; P = 0.000) for soluble triggering 
receptor expressed on myeloid cells-1 (sTREM-1), 0.77 (95% CI 0.54 
to 0.84; P = 0.001) for percentage of neutrophils in bronchoalveolar 
lavage fluid, and 0.69 (95% CI 0.54 to 0.84; P = 0.023) for Clinical 
Pulmonary Infection Score (CPIS).Critical Care    Vol 12 No 1    Huh et al.
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neutrophils and monocytes. Moreover, lipopolysaccharides,
bacteria, and fungi upregulate sTREM-1 expression [10,12-
15].
The present study has several limitations. First, because most
of the false-positive results in sTREM-1 levels involved diffuse
alveolar hemorrhage, which was not included in other investi-
gations [4,16,18,25], the utility of sTREM-1 in this group
remains to be determined. Second, some patients may have
suffered from noninfectious inflammatory disease combined
with infection, although two blinded investigators determined
each patient's diagnosis without knowledge of the sTREM-1
concentration. Third, the sTREM level measured in BAL fluid is
lower as a result of dilution and may differ from the actual con-
centrations in some patients, although we performed exactly
the same technique and retrieved similar volumes in the three
groups (data not shown). Finally, cases of fungal pneumonia
were rare.
Conclusion
The sTREM-1 level in BAL fluid from patients with bilateral lung
infiltrates is a potential marker for the differential diagnosis of
pneumonia due to extracellular bacteria. We propose that the
sTREM-1 level (184 pg/ml or more, versus less than 184 pg/
ml) is a more useful marker than clinical criteria in refining the
diagnostic spectrum (bacterial infection versus others) in
patients presenting bilateral lung infiltrates.
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